• Issue

    Cancer Communications: Volume 39, Issue 1

    1-9
    December 2019
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Article

NCT01917279

NCT

Open Access

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

Xiuwen Guan,  Fei Ma,  Chunxiao Li,  Shiyang Wu,  Shangying Hu,  Jiefen Huang,  Xiaoying Sun,  Jiayu Wang,  Yang Luo,  Ruigang Cai,  Ying Fan,  Qiao Li,  Shanshan Chen,  Pin Zhang,  Qing Li,  Binghe Xu, 
  • Pages: 1-10
  • First Published: 03 January 2019

Research Highlight

Open Access

A novel role of LncRNA in regulating tumor metabolism and angiogenesis under hypoxia

Jie Luo,  Lee F. Langer,  Jian Liu, 
  • Pages: 1-3
  • First Published: 04 February 2019

Original Article

Open Access

TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis

Dan-dan Wang,  Yi-bing Chen,  Jing-jing Zhao,  Xiao-fei Zhang,  Guang-chao Zhu,  De-sheng Weng,  Ke Pan,  Lin Lv,  Qiu-zhong Pan,  Shan-shan Jiang,  Lei-lei Wang,  Jian-chuan Xia, 
  • Pages: 1-14
  • First Published: 06 February 2019
Open Access

Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis

Jian-Xian Lin,  Zu-Kai Wang,  Jian-Wei Xie,  Jia-Bin Wang,  Jun Lu,  Qi-Yue Chen,  Long-Long Cao,  Mi Lin,  Ru-Hong Tu,  Ze-Ning Huang,  Ju-Li Lin,  Chao-Hui Zheng,  Chang-Ming Huang,  Ping Li, 
  • Pages: 1-11
  • First Published: 11 February 2019

Study Protocol

ChiCTR-OID-17013702

ChiCTR-OID

Open Access

Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial

Lin Kong,  Jing Gao,  Jiyi Hu,  Rong Lu,  Jing Yang,  Xianxin Qiu,  Weixu Hu,  Jiade J. Lu, 
  • Pages: 1-12
  • First Published: 20 February 2019

Correction

Open Access

Correction to: Incidence, mortality, and temporal patterns of oropharyngeal cancer in China: a population-based study

Jie Liu,  Xu-li Yang,  Si-Wei Zhang,  Li-Ping Zhu,  Wan-Qing Chen, 
  • Page: 1
  • First Published: 26 February 2019

Original Article

Open Access

Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations

Fang Wang,  Xia-Yao Diao,  Xiao Zhang,  Qiong Shao,  Yan-Fen Feng,  Xin An,  Hai-Yun Wang, 
  • Pages: 1-15
  • First Published: 02 March 2019

Letter to the Editor

Open Access

Skull bone tumor: a review of clinicopathological and neuroimaging characteristics of 426 cases at a single center

Hailong Liu,  Xueying Zhang,  Mingshan Zhang,  Junping Zhang,  Weihai Ning,  Angela Yue,  Rugang Zhao,  Youliang Sun,  Chunjiang Yu, 
  • Pages: 1-5
  • First Published: 08 March 2019

Research Highlight

Open Access

Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer

Dunyaporn Trachootham,  Watcharapol Khoonin, 
  • Pages: 1-3
  • First Published: 12 March 2019

Guideline and Consensus

Open Access

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

Feng-Hua Wang,  Lin Shen,  Jin Li,  Zhi-Wei Zhou,  Han Liang,  Xiao-Tian Zhang,  Lei Tang,  Yan Xin,  Jing Jin,  Yu-Jing Zhang,  Xiang-Lin Yuan,  Tian-Shu Liu,  Guo-Xin Li,  Qi Wu,  Hui-Mian Xu,  Jia-Fu Ji,  Yuan-Fang Li,  Xin Wang,  Shan Yu,  Hao Liu,  Wen-Long Guan,  Rui-Hua Xu, 
  • Pages: 1-31
  • First Published: 18 March 2019

Review

Open Access

Recent trends from the results of clinical trials on gastric cancer surgery

Takashi Kiyokawa,  Takeo Fukagawa, 
  • Pages: 1-7
  • First Published: 27 March 2019
Open Access

Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

Chang Zeng,  Emily Kunce Stroup,  Zhou Zhang,  Brian C.-H. Chiu,  Wei Zhang, 
  • Pages: 1-9
  • First Published: 29 March 2019
Open Access

Mucinous colorectal adenocarcinoma: clinical pathology and treatment options

Cong Luo,  Shuyi Cen,  Guojun Ding,  Wei Wu, 
  • Pages: 1-13
  • First Published: 29 March 2019

Original Article

Open Access

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

Sai-Lan Liu,  Xue-Song Sun,  Xiao-Yun Li,  Lin-Quan Tang,  Qiu-Yan Chen,  Huan-Xin Lin,  Yu-Jing Liang,  Jin-Jie Yan,  Chao Lin,  Shan-Shan Guo,  Li-Ting Liu,  Yang Li,  Hao-Jun Xie,  Qing-Nan Tang,  Hu Liang,  Ling Guo,  Hai-Qiang Mai, 
  • Pages: 1-13
  • First Published: 29 March 2019

Letter to the Editor

Open Access

Primary intrathoracic liposarcoma: a clinical analysis of 31 cases

Zhixue Fu,  Kun Yang,  Xu Yang,  Shulan Chen,  Wenqing Wang,  Dongfu Chen,  Jun Zhao,  Zhishan Li,  Qinfu Feng,  Zongmei Zhou,  Luhua Wang,  Shugeng Gao,  Jun Liang, 
  • Pages: 1-3
  • First Published: 02 April 2019

Original Article

NCT02319187

NCT

Open Access

Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial

Jing Huang,  Binghe Xu,  Ying Liu,  Junxing Huang,  Ping Lu,  Yi Ba,  Lin Wu,  Yuxian Bai,  Shu Zhang,  Jifeng Feng,  Ying Cheng,  Jie Li,  Lu Wen,  Xianglin Yuan,  Changwu Ma,  Chunhong Hu,  Qingxia Fan,  Xi Wang, 
  • Pages: 1-10
  • First Published: 02 April 2019
Open Access

Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis

Xin You,  Weiye Jiang,  Wenhua Lu,  Hui Zhang,  Tiantian Yu,  Jingyu Tian,  Shijun Wen,  Guillermo Garcia-Manero,  Peng Huang,  Yumin Hu, 
  • Pages: 1-13
  • First Published: 04 April 2019

Letter to the Editor

Open Access

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma

Dehuan Xie,  Wanqin Cheng,  Shaowen Lv,  Rui Zhong,  Lei Wang,  Jiang Hu,  Mingli Wang,  Shaomin Huang,  Yong Su,  Yunfei Xia, 
  • Pages: 1-4
  • First Published: 15 April 2019

Original Article

Open Access

An improved ileal conduit surgery for bladder cancer with fewer complications

Zhiyong Li,  Zhuowei Liu,  Kai Yao,  Zike Qin,  Hui Han,  Yonghong Li,  Pei Dong,  Yunlin Ye,  Yanjun Wang,  Zhiming Wu,  Zhiling Zhang,  Fangjian Zhou, 
  • Pages: 1-10
  • First Published: 18 April 2019

Letter to the Editor

Open Access

Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer

Jie Zhang,  Chen Tian,  Fang Lv,  Jianfei Wang,  Wenbo Han,  Jun Nie,  Ling Dai,  Weiheng Hu,  Xiaoling Chen,  Xiangjuan Ma,  Guangming Tian,  Di Wu,  Sen Han,  Yang Wang,  Jieran Long,  Ziran Zhang,  Jian Fang,  Henghui Zhang, 
  • Pages: 1-5
  • First Published: 18 April 2019

Review

Open Access

Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer

Tong Wu,  Xuan Wu,  Hong-Yang Wang,  Lei Chen, 
  • Pages: 1-9
  • First Published: 18 April 2019

Short Report

Open Access

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Rui-Mei Feng,  Yi-Nan Zong,  Su-Mei Cao,  Rui-Hua Xu, 
  • Pages: 1-12
  • First Published: 29 April 2019

Original Article

Open Access

Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance

Wai Hoong Chang,  Donall Forde,  Alvina G. Lai, 
  • Pages: 1-14
  • First Published: 29 April 2019
Open Access

National trend of gastric cancer mortality in China (2003–2015): a population-based study

Kun Gao,  Jun Wu, 
  • Pages: 1-5
  • First Published: 02 May 2019
Open Access

Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?

Jin Wang,  Hailin Tang,  Xing Li,  Cailu Song,  Zhenchong Xiong,  Xi Wang,  Xiaoming Xie,  Jun Tang, 
  • Pages: 1-12
  • First Published: 08 May 2019

NCT02028806

NCT

Open Access

The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

Zhi-Qiang Wang,  Fei Zhang,  Ting Deng,  Le Zhang,  Fen Feng,  Feng-Hua Wang,  Wei Wang,  De-Shen Wang,  Hui-Yan Luo,  Rui-Hua Xu,  Yi Ba,  Yu-Hong Li, 
  • Pages: 1-8
  • First Published: 08 May 2019

Letter to the Editor

Open Access

Is cancer-related death associated with circadian rhythm?

Shing Fung Lee,  Miguel Angel Luque-Fernandez, 
  • Pages: 1-5
  • First Published: 14 May 2019

Original Article

NCT01550055

NCT

Open Access

CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial

Yuankai Shi,  Jin Li,  Jianming Xu,  Yan Sun,  Liwei Wang,  Ying Cheng,  Wei Liu,  Guoping Sun,  Yigui Chen,  Li Bai,  Yiping Zhang,  Xiaohui He,  Yi Luo,  Zhehai Wang,  Yunpeng Liu,  Qiang Yao,  Yuhong Li,  Shukui Qin,  Xiaohua Hu,  Feng Bi,  Rongsheng Zheng,  Xuenong Ouyang, 
  • Pages: 1-13
  • First Published: 24 May 2019
Open Access

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

Ji-Yeon Kim,  Seri Park,  Seock-Ah Im,  Sung-Bae Kim,  Joohyuk Sohn,  Keun Seok Lee,  Yee Soo Chae,  Ki Hyeong Lee,  Jee Hyun Kim,  Young-Hyuck Im,  Tae-Yong Kim,  Kyung-Hun Lee,  Jin-Hee Ahn,  Gun Min Kim,  In Hae Park,  Soo Jung Lee,  Hye Sook Han,  Se Hyun Kim,  Kyung Hae Jung,  Yeon Hee Park,  Korean Cancer Study Group , 
  • Pages: 1-8
  • First Published: 28 May 2019
Open Access

PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer

Trine Vilsbøll Larsen,  Dianna Hussmann,  Anders Lade Nielsen, 
  • Pages: 1-14
  • First Published: 03 June 2019
Open Access

Modelling the probability of erroneous negative lymph node staging in patients with colon cancer

Carlos Fortea-Sanchis,  Erica Forcadell-Comes,  David Martínez-Ramos,  Javier Escrig-Sos, 
  • Pages: 1-10
  • First Published: 06 June 2019
Open Access

A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes

Sharvesh Raj Seeruttun,  Lipu Xu,  Fangwei Wang,  Xiaodong Yi,  Cheng Fang,  Zhimin Liu,  Wei Wang,  Zhiwei Zhou, 
  • Pages: 1-11
  • First Published: 10 June 2019

Letter to the Editor

Open Access

Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes?

Yaxiong Zhang,  Lianpeng Chang,  Wenfeng Fang,  Yunpeng Yang,  Lanjun Zhang,  Shaodong Hong,  Huaqiang Zhou,  Yanfang Guan,  Xin Yi,  Li Zhang, 
  • Pages: 1-4
  • First Published: 13 June 2019

Review

Open Access

Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells

Jean-François Rossi,  Patrice Céballos,  Zhao-Yang Lu, 
  • Pages: 1-16
  • First Published: 14 June 2019

Letter to the Editor

Open Access

Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer

Romano Demicheli,  Marco Fornili,  Patrizia Querzoli,  Massimo Pedriali,  Saverio Alberti,  Christine Desmedt,  Elia Biganzoli, 
  • Pages: 1-4
  • First Published: 19 June 2019

Review

Open Access

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy

Ming Zhou,  Xiaoyuan Chen,  Hong Zhang,  Lin Xia,  Xin Tong,  Limin Zou,  Ruimin Hao,  Jianhong Pan,  Xiao Zhao,  Dongmei Chen,  Yuanyuan Song,  Yueli Qi,  Ling Tang,  Zhifang Liu,  Rong Gao,  Yuankai Shi,  Zhimin Yang, 
  • Pages: 1-10
  • First Published: 20 June 2019

Letter to the Editor

Open Access

Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression

Jie Wang,  Jianzhong Xi,  Hanshuo Zhang,  Juan Li,  Yuchao Xia,  Ruibin Xi,  Zhijun Xi, 
  • Pages: 1-6
  • First Published: 21 June 2019

Original Article

NCT01774786

NCT

Open Access

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

Tianshu Liu,  Yanru Qin,  Jin Li,  Ruihua Xu,  Jianming Xu,  Shujun Yang,  Shukui Qin,  Yuxian Bai,  Changping Wu,  Yixiang Mao,  Haiyan Wu,  Yilin Ge,  Lin Shen, 
  • Pages: 1-10
  • First Published: 24 June 2019

Editorial

Open Access

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma

Yuan Zhang,  Ying Sun,  Jun Ma, 
  • Pages: 1-4
  • First Published: 25 June 2019

Original Article

Open Access

Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis

Jun-Fang Liao,  Qun Zhang,  Xiao-Jing Du,  Mei Lan,  Shan Liu,  Yun-Fei Xia,  Xiu-Yu Cai,  Wei Luo, 
  • Pages: 1-11
  • First Published: 27 June 2019

Open Access

Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells

Christophe Glorieux,  Peng Huang, 
  • Pages: 1-11
  • First Published: 09 July 2019

NCT03291106

NCT

Open Access

Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China

Xiaopei Chao,  Lei Li,  Ming Wu,  Shuiqing Ma,  Xianjie Tan,  Sen Zhong,  Yalan Bi,  Jinghe Lang, 
  • Pages: 1-12
  • First Published: 15 July 2019

Review

Open Access

Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

Jing-Bo Wang,  Xue Huang,  Fu-Rong Li, 
  • Pages: 1-11
  • First Published: 15 July 2019

Letter to the Editor

Open Access

Clinical outcomes of angiosarcoma: a single institution experience

Jae-Joon Kim,  Seyoung Seo,  Jeong Eun Kim,  Sung-Ho Jung,  Si Yeol Song,  Jin-Hee Ahn, 
  • Pages: 1-4
  • First Published: 06 August 2019

Research Highlight

Open Access

Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France

Haibo Qiu, 
  • Pages: 1-3
  • First Published: 08 August 2019

Study Protocol

NCT03775369

NCT

Open Access

Effects of two types of exercise training on psychological well-being, sleep, quality of life and physical fitness in patients with high-grade glioma (WHO III and IV): study protocol for a randomized controlled trial

Dominik Cordier,  Markus Gerber,  Serge Brand, 
  • Pages: 1-10
  • First Published: 09 August 2019

Letter to the Editor

Open Access

Radiation pneumonitis complicated by Pneumocystis carinii in patients with thoracic neoplasia: a clinical analysis of 7 cases

Zhixue Fu,  Xu Yang,  Nan Bi,  Yirui Zhai,  Dongfu Chen,  Wenqing Wang,  Lei Deng,  Tao Zhang,  Zongmei Zhou,  Jun Liang, 
  • Pages: 1-4
  • First Published: 23 August 2019

Review

Open Access

Cancer cell reprogramming: a promising therapy converting malignancy to benignity

Lanqi Gong,  Qian Yan,  Yu Zhang,  Xiaona Fang,  Beilei Liu,  Xinyuan Guan, 
  • Pages: 1-13
  • First Published: 29 August 2019

Original Article

Open Access

Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis

Siwei Pan,  Pengliang Wang,  Yanan Xing,  Kai Li,  Zhenning Wang,  Huimian Xu,  Zhi Zhu, 
  • Pages: 1-12
  • First Published: 13 September 2019

Correction

Open Access

Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis

Jun-Fang Liao,  Qun Zhang,  Xiao-Jing Du,  Mei Lan,  Shan Liu,  Yun-Fei Xia,  Xiu-Yu Cai,  Wei Luo, 
  • Page: 1
  • First Published: 23 September 2019

Letter to the Editor

Open Access

Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience

Qian Zhao,  Feng Li,  Ping Song,  Xiaogang Zhou,  Zhiming An,  Jiangang Mei,  Jingjing Shao,  Hanqing Li,  Xuli Wang,  Xing Guo,  Yongping Zhai, 
  • Pages: 1-6
  • First Published: 27 September 2019

Research Highlight

Open Access

A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer

Jian Ma,  Burton B. Yang, 
  • Pages: 1-3
  • First Published: 01 October 2019

Review

Open Access

Pathological transition as the arising mechanism for drug resistance in lung cancer

Yueqing Chen,  Waiying Yvonne Tang,  Xinyuan Tong,  Hongbin Ji, 
  • Pages: 1-13
  • First Published: 01 October 2019

Original Article

Open Access

Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis

Fei Shao,  Xueying Yang,  Wei Wang,  Juhong Wang,  Wei Guo,  Xiaoli Feng,  Susheng Shi,  Qi Xue,  Shugeng Gao,  Yibo Gao,  Zhimin Lu,  Jie He, 
  • Pages: 1-17
  • First Published: 02 October 2019
Open Access

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy

Yang-Xun Pan,  Jian-Cong Chen,  Ai-Ping Fang,  Xiao-Hui Wang,  Jin-Bin Chen,  Jun-Cheng Wang,  Wei He,  Yi-Zhen Fu,  Li Xu,  Min-Shan Chen,  Yao-Jun Zhang,  Qi-Jiong Li,  Zhong-Guo Zhou, 
  • Pages: 1-11
  • First Published: 11 October 2019

Letter to the Editor

Open Access

Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study

Wen Cai,  Biao Cai,  Juan Zhou,  Yonghui Chen,  Jin Zhang,  Yiran Huang,  Wei Xue,  Jiwei Huang, 
  • Pages: 1-4
  • First Published: 11 October 2019

Original Article

Open Access

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

Shaoyan Lin,  Jian Yue,  Xiuwen Guan,  Peng Yuan,  Jiayu Wang,  Yang Luo,  Ying Fan,  Ruigang Cai,  Qiao Li,  Shanshan Chen,  Pin Zhang,  Qing Li,  Fei Ma,  Binghe Xu, 
  • Pages: 1-12
  • First Published: 11 October 2019

NCT01213095

NCT

Open Access

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study

Sung Yong Oh,  Won Seog Kim,  Jin Seok Kim,  Seok Jin Kim,  Dok Hyun Yoon,  Deok-Hwan Yang,  Won Sik Lee,  Hyo Jung Kim,  Ho-Young Yhim,  Seong Hyun Jeong,  Jong Ho Won,  Suee Lee,  Jee Hyun Kong,  Sung-Nam Lim,  Jun Ho Ji,  Kyung A. Kwon,  Gyeong-Won Lee,  Jae Hoon Lee,  Ho Sup Lee,  Ho-Jin Shin,  Cheolwon Suh, 
  • Pages: 1-10
  • First Published: 16 October 2019
Open Access

Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience

Jianhong Peng,  Weihao Li,  Rongxin Zhang,  Junzhong Lin,  Jinghua Tang,  Yongshan Wen,  Zhenhai Lu,  Xiaojun Wu,  Zhizhong Pan, 
  • Pages: 1-12
  • First Published: 16 October 2019
Open Access

Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database

Gary D. Lewis,  Yan Xing,  Waqar Haque,  Tejal Patel,  Mary Schwartz,  Albert Chen,  Andrew Farach,  Sandra S. Hatch,  E. Brian Butler,  Jenny Chang,  Bin S. Teh, 
  • Pages: 1-9
  • First Published: 21 October 2019

Mini Review

Open Access

New frontiers in proton therapy: applications in cancers

Tai-Ze Yuan,  Ze-Jiang Zhan,  Chao-Nan Qian, 
  • Pages: 1-7
  • First Published: 22 October 2019

Original Article

Open Access

Incidence trends and survival prediction of hepatoblastoma in children: a population-based study

Jincheng Feng,  Georgios Polychronidis,  Ulrike Heger,  Giovanni Frongia,  Arianeb Mehrabi,  Katrin Hoffmann, 
  • Pages: 1-9
  • First Published: 24 October 2019

Research Highlight

Open Access

Targeting mitochondria as an anticancer strategy

Lanfeng Dong,  Jiri Neuzil, 
  • Pages: 1-3
  • First Published: 25 October 2019
Open Access

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma

Li-Ting Liu,  Melvin L. K. Chua,  Yungan Tao,  Lin-Quan Tang,  Hai-Qiang Mai, 
  • Pages: 1-3
  • First Published: 25 October 2019
Open Access

S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer

Feiyu Diao,  Wei Lai,  Zhonghua Chu, 
  • Pages: 1-3
  • First Published: 26 October 2019

Original Article

Open Access

Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis

Wentao Zhou,  Weiwei Jin,  Dansong Wang,  Chao Lu,  Xuefeng Xu,  Renchao Zhang,  Tiantao Kuang,  Yucheng Zhou,  Wenchuan Wu,  Dayong Jin,  Yiping Mou,  Wenhui Lou, 
  • Pages: 1-11
  • First Published: 28 October 2019

Letter to the Editor

Open Access

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment

Hideharu Kimura,  Yoshiaki Amino,  Hayato Koba,  Yuichi Tambo,  Noriyuki Ohkura,  Johsuke Hara,  Takashi Sone,  Kazuo Kasahara, 
  • Pages: 1-5
  • First Published: 01 November 2019

Original Article

Open Access

Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification

Zhi-Xia Yue,  Tian-Yu Xing,  Chao Gao,  Shu-Guang Liu,  Wen Zhao,  Qian Zhao,  Xi-Si Wang,  Mei Jin,  Xiao-Li Ma, 
  • Pages: 1-9
  • First Published: 04 November 2019